Want to see IN:DRREDDY full AI Analyst Report?
Dr. Reddy's Laboratories Ltd. (DRREDDY) Stock Forecast & Price Target
DRREDDY Analyst Ratings
DRREDDY Stock 12 Month Forecast
Average Price Target
INR 1,346.67▼(-0.26% Downside)Detailed List of Analyst Forecasts
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
| Bansi Desai | J.P. Morgan | INR 1,100→INR 1,270 | hold | -5.94%Downside | Upgraded | 10/25/26 | ||
| Alok Dalal | Jefferies | INR 1,320 | hold | -2.24%Downside | Upgraded | 10/25/26 | ||
| Vivek Agrawal CFA | Citi | INR 1,040→INR 1,450 | buy | 7.39%Upside | Upgraded | 09/28/26 | ||
| Shyam Srinivasan | Goldman Sachs | INR 1,075 | sell | -20.38%Downside | Downgraded | 04/23/26 | ||
 Unknown AnalystNot Ranked | Geojit Research | INR 1,390 | hold | 2.95%Upside | Reiterated | 02/23/26 | ||
| Neha Manpuria | Bank of America Securities | INR 1,600 | buy | 18.50%Upside | Reiterated | 12/15/25 | ||
| Unknown AnalystNot Ranked | Motilal Oswal | INR 1,250 | hold | -7.42%Downside | Reiterated | 12/12/25 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Bansi Desai | 10/25/26 | INR 1,100→INR 1,270 | hold | -5.94%Downside | Upgraded | J.P. Morgan | ||
| Alok Dalal | 10/25/26 | INR 1,320 | hold | -2.24%Downside | Upgraded | Jefferies | ||
| Vivek Agrawal CFA | 09/28/26 | INR 1,040→INR 1,450 | buy | 7.39%Upside | Upgraded | Citi | ||
| Shyam Srinivasan | 04/23/26 | INR 1,075 | sell | -20.38%Downside | Downgraded | Goldman Sachs | ||
| Unknown AnalystNot Ranked | 02/23/26 | INR 1,390 | hold | 2.95%Upside | Reiterated | Geojit Research | ||
| Neha Manpuria | 12/15/25 | INR 1,600 | buy | 18.50%Upside | Reiterated | Bank of America Securities | ||
| Unknown AnalystNot Ranked | 12/12/25 | INR 1,250 | hold | -7.42%Downside | Reiterated | Motilal Oswal |
Best Analysts Covering Dr. Reddy's Laboratories Ltd.
Copying Vivek Agrawal CFA's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +6.75% per trade.
Copying Vivek Agrawal CFA's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +3.00% per trade.
Copying Vivek Agrawal CFA's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +7.60% per trade.
DRREDDY Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 1 | 3 | 3 |
In the current month, DRREDDY has received 1 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. DRREDDY average Analyst price target in the past 3 months is 1,346.67.
DRREDDY Financial Forecast
DRREDDY Earnings Forecast
Next quarter’s earnings estimate for DRREDDY is INR 11.90 with a range of INR 11.18 to INR 12.30. The previous quarter’s EPS was INR 11.10. DRREDDY beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 50.49% of the time in the same period. In the last calendar year DRREDDY has Performed in-line its overall industry.
DRREDDY Sales Forecast
Next quarter’s sales forecast for DRREDDY is INR 90.61B with a range of INR 89.24B to INR 93.09B. The previous quarter’s sales results were INR 86.71B. DRREDDY beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 63.25% of the time in the same period. In the last calendar year DRREDDY has Performed in-line its overall industry.